ѻý

<ѻý class="page-title">Meeting Coverage

ACR Video Pearls: PsA

<ѻý class="page-description">Video Pearls from the American College of Rheumatology
How Do You Select Systemic Therapy for Your Psoriasis Patients?

Richard Warren explains the factors he considers and what his "go-to" treatment is

image
<ѻý class="section_title">Latest ACR Video Pearls: PsA Meeting Coverage
Deucravacitinib Improves Joint Symptoms in Psoriatic Arthritis

Greater improvements over apremilast and placebo through 24 weeks

December 5, 2023
Simplified Assessment Tool for Psoriatic Arthritis Performs Well

Philip Mease, MD, says this new instrument could be reliable in clinical practice

November 28, 2023
Guselkumab for PsA Yields 'Meaningful Improvements' in Quality of Life

Philip Mease, MD, discusses real-world data presented at the ACR annual meeting

November 21, 2023
Age at PsA Onset Correlates With Different Outcomes

Late-onset PsA tied to worse functionality and more structural damage

December 14, 2022
Opioid Use in PsA, Ankylosing Spondylitis Tied to More Healthcare Utilization

Alexis Ogdie-Beatty, MD, says we need to turn to other items in our treatment toolbox

December 7, 2022
Bimekizumab Improves Pain, Fatigue in Patients With Active PsA

Health-related quality-of-life scores showed improvements as early as week 4

November 30, 2022
PsA Patients See Long-Term Improvements in Quality of Life With Guselkumab

Philip Mease, MD, discusses the DISCOVER-2 abstracts presented at the ACR annual meeting

November 23, 2022
<ѻý class="section_title">Videos
ACR
November 2023
EULAR
June 2024